A selective inhibitor of the osteoclastic V-H+-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats

Journal of Clinical Investigation

Volumn 106, Issue 2, 2000, Pages 309-318

  Visentin, Luciano ^a   Dodds, Robert A ^b   Valente, Maurizio ^a   Misiano, Paola ^a   Bradbeer, Jeremy N ^b   Oneta, Sergio ^a   Liang, Xiaoguang ^b   Gowen, Maxine ^b   Farina, Carlo ^a  

^a SmithKline Beecham SpA   (Italy)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (5,6 DICHLORO 2 INDOLYL) 2 METHOXY N (1,2,2,6,6 PENTAMETHYLPIPERIDIN 4 YL) 2,4 PENTADIENAMIDE; ADENOSINE TRIPHOSPHATASE INHIBITOR; SB 242784; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE DENSITY; DRUG MECHANISM; DRUG POTENCY; MALE; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; THYROPARATHYROIDECTOMY;

EID: 0033941575     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6145     Document Type: Article

References (46)

1. Dempster, D.W., and Lindsay, R. 1993. Pathogenesis of osteoporosis. Lancet. 341:797-801.
2. Baron, R., Neff, L., Louvard, D., and Courtoy, P.J. 1985. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100 kD lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 101:2210-2222.
3. Hall, T.J., and Chambers, T.J. 1996. Molecular aspects of osteoclast function. Inflamm. Res. 45:1-9.
4. Blair, H.C., Teitelbaum, S.M., Ghiselli, R., and Gluck, S. 1989. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science. 245:855-857.
5. +-ATPase: a universal proton pump of eukaryotes. Biochem. J. 324:697-712.
6. Bowmann, E.J., Siebers, A., and Altendorf, K. 1988. Bafilomycin: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA. 85:7972-7976.
7. 1 abolishes bone resorption. Biochem. Biophys. Res. Commun. 168:309-313.
8. 1 inhibits bone resorption in vivo after systemic administration. J. Bone Miner. Res. 10(Suppl. 1):S296. (Abstr.)
9. Keeling, D.J., Herslof, M., Mattsson, J.P., and Ryberg, B. 1998. Tissue-selective inhibition of vacuolar acid pumps. Acta Physiol. Scand. 643:195-201.
10. +-ATPase of osteoclasts with bone antiresorptive activity. J. Med. Chem. 41:1568-1573.
11. Nadler, G., et al. 1998. (2Z,4E)-5-(5,6-Dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6-pentamethylpiperidin- 4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase. Bioorg. Med. Chem. Lett. 24:3621-3626.
12. +-ATPase activity: a new concept in cytochemistry. Histochemistry. 71:533-541.
13. Trechsel, U., Stutzer, A., and Fleisch, H. 1987. Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. J. Clin. Invest. 80:1679-1686.
14. Loeliger, P., Bollag, W., and Mayer, H. 1980. Arotinoids, a new class of highly active retinoids. Eur. J. Med. Chem. - Chim. Ther. 15:9-15.
15. Wronski, T.J., Cintron, M., Doherty, A.L., and Dann, L.M. 1988. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology. 123:681-686.
16. Wronski, T.J., Yen, C.F., and Scott, K.S. 1991. Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J. Bone Miner. Res. 6:387-394.
17. Eyre, D.R., Koob, T.J., and Van Ness, K.P. 1984. Quantitation of hydroxypyridinium cross links in collagen by high-performance liquid chromatography. Anal. Biochem. 137:380-388.
18. +-ATPase, prevents bone loss in both growing and mature ovariectomized rats. J. Bone Miner. Res. 12(Suppl. 1):S478. (Abstr.)
19. Jerome, C.P., et al. 1994. Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry. J. Bone Miner. Res. 9:527-540.
20. Yamamoto, M., et al. 1998. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Endocrinology. 139:1411-1419.
21. Laitala, T., and Vaananen, H.K. 1993. Proton channel part of vacuolar H(+)-ATPase and carbonic anhydrase II expression is stimulated in resorbing osteoclasts. J. Bone Miner. Res. 8:119-126.
22. Laitala, T., and Vaananen, H.K. 1994. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. J. Clin. Invest. 93:2311-2318.
23. Forgac, M. 1996. Regulation of vacuolar acidification. Soc. Gen. Physiol. Ser. 51:121-132.
24. Lee, B.S., Holliday, L.S., Ojikutu, B., and Gluck, S.L. 1996. Osteoclasts express the B2 isoform of vacuolar H(+)-ATPase intracellularly and on their plasma membranes. Am. J. Physiol. 270:C382-C388.
25. Mattsson, J.P., et al. 1997. Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies. J. Bone Miner. Res. 12:753-760.
26. Van Hille, B.V., Vanek, M., Richener, H., Green, J.R., and Bilbe, G. 1993. Cloning and tissue distribution of subunits C, D, and E of the human vacuolar H(+)-ATPase. Biochem. Biophys. Res. Commun. 197:15-21.
27. Hernando, N., Bartkiewicz, M., Collin-Osbody, P., Osbody, P., and Baron, R. 1995. Alternative splicing generates a second isoform of the catalytic A subunit of the vacuolar H(+)-ATPase. Proc. Natl. Acad. Sci. USA. 92:6087-6091
28. Van Hille, B., Richener, H., Evans, D.B., Green, J.R., and Bilbe, G. 1993. Identification of two subunit A isoforms of the vacuolar H(+)-ATPase in human osteoclastoma. J. Biol. Chem. 268:7075-7080.
29. Li, Y.P., Chen, W., and Stashenko, P. 1996. Molecular cloning and characterization of a putative novel human osteoclast-specific 116-kD vacuolar proton pump subunit. Biochem. Biophys. Res. Commun. 218:813-821.
30. Van Hille, B., Richener, H., Green, J.R., and Bilbe, G. 1995. The ubiquitous VA68 isoform of subunit A of the vacuolar H(+)-ATPase is highly expressed in human osteoclasts. Biochem. Biophys Res. Commun. 214:1108-1113.
31. Scott, B.B., and Chapman, C.G. 1998. The putative 116 kD osteoclast specific vacuolar proton pump subunit has ubiquitous tissue distribution. Eur. J. Pharmacol. 346:R3-R4.
32. Chatterjee, D., et al. 1992. Sensitivity to vanadate and isoforms of subunits A and B distinguish the osteoclast proton pump from other vacuolar ATPases. Proc. Natl. Acad. Sci. USA. 89:6257-6261.
33. Chatterjee, D., Neff, L., Chakraborty, M., Fabricant, C., and Baron, R. 1993. Sensitivity to nitrate and other oxyanions further distinguishes the vanadate-sensitive osteoclast proton pump from other vacuolar ATPases. Biochemistry. 32:2808-2812.
34. Mattsson, J.P., et al. 1993. Isolation and reconstitution of a vacuolar-type proton pump of osteoclast membranes. Biochem. Biophys. Acta. 1146:106-112.
35. Mattsson, J.P., Lorentzon, P., Wallmark, B., and Keeling, D.J. 1994. Characterization of proton transport in bone-derived membrane vesicles. J. Biol. Chem. 269:24979-24982.
36. +-ATPase. Bone Miner. 27:159-166.
37. Manolson, M.F., Landolt-Marticorena, C., Yu, H., Williams, K.M., and Heersche, J. 1999. Topology and function of the 116 kD V-ATPase subunit in osteoclasts and yeast. J. Bone Miner. Res. 14(Suppl. 1):S484. (Abstr.)
38. Li, Y.P., Chen, W., Lieng, Y., Li, E., and Stashenko, P. 1999. ATP6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23:447-451.
39. Yu, E., Chen, W., Lees, R., Heersche, J., and Manolson, M.F. 1998. Identification of vacuolar-type proton-ATPase subunits unique to osteoclasts. Bone. 23(Suppl.):S549. (Abstr.)
40. +-ATPase genes: presence of four genes including pseudogenes for the 16-kD proteolipid subunit in the human genome. Biochem. Biophys. Res. Commun. 183:856-863.
41. Kalu, D.M. 1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 25:175-192.
42. Robins, S.P., Duncan, A., and Riggs, B.L. 1990. Direct measurement of free hydroxy-pyridinium crosslinks of collagen in urine as new markers of bone resorption in osteoporosis. In Osteoporosis. C. Christiansen and K. Overgaard, editors. Ostopress. Copenhagen, Denmark. 465-468.
43. Eastell, R., Colwell, A., Hampton, L., and Reeve, J. 1997. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J. Bone Miner. Res. 12:59-65.
44. Delmas, P.D., Schlemmer, A., Gineyts, E., Riis, B., and Christiansen, C. 1991. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patient with vertebral osteoporosis. J. Bone Miner. Res. 6:639-644.
45. Siebel, M.J., Robins, S.P., and Bilezikian, J.P. 1992. Urinary pyridinium crosslinks of collagen. Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol. Metab. 3:263-270.
46. Bastani, B., Purcel, H., Hemken, P., Trigg, D., and Gluck, S. 1991. Expression and distribution of renal vacuolar proton-translocating adenosinetriphosphatase in response to chronic acid and alkali loads in the rat. J. Clin. Invest. 88:126-136.